back conversion test [Regulatives / Guidelines]

posted by Thair Saleh – Jordan, 2024-07-01 11:42 (16 d 15:22 ago) – Posting: # 24050
Views: 312

dear Colleagues


in the case of metabolites, (unstable N-oxides or glucuronide metabolites, lactone-ring structures) found in the drug should always covered by the back conversion test, or there is a limit (2%, 5%, 10%) of the drug if the metabolite exceeds then should be covered.

Complete thread:

UA Flag
Activity
 Admin contact
23,107 posts in 4,858 threads, 1,644 registered users;
64 visitors (0 registered, 64 guests [including 11 identified bots]).
Forum time: 03:04 CEST (Europe/Vienna)

All paid jobs absorb and degrade the mind.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5